Dermatomyositis and malignancy.
作者信息
Hu Tina, Vinik Ophir
机构信息
Family medicine resident at St Michael's Hospital at the University of Toronto in Ontario.
Staff rheumatologist at St Michael's Hospital and Assistant Professor of Medicine at the University of Toronto.
出版信息
Can Fam Physician. 2019 Jun;65(6):409-411.
Abstract
摘要
相似文献
1
Dermatomyositis and malignancy.
Can Fam Physician. 2019 Jun;65(6):409-411.
2
Rothmann-Makai syndrome with infiltrative ductal mammary cancer: coexistence or association?
J Eur Acad Dermatol Venereol. 2003 Jul;17(4):479-80. doi: 10.1046/j.1468-3083.2003.00614_7.x.
3
Localized neurofibromatosis associated with chronic post-mastectomy lymphoedema--a case report.
Eur J Surg Oncol. 1996 Feb;22(1):114-5. doi: 10.1016/s0748-7983(96)91913-7.
4
Invasive breast cancer.
J Natl Compr Canc Netw. 2007 Mar;5(3):246-312. doi: 10.6004/jnccn.2007.0025.
5
A case of erythema elevatum diutinum associated with breast carcinoma.
Int J Dermatol. 2005 Nov;44(11):948-50. doi: 10.1111/j.1365-4632.2004.02333.x.
6
A fresh look at DCIS treatment. Study raises questions about current approaches to treating stage 0 breast cancer.
Health After 50 Sci Am Consum Health. 2016 Winter;27(14):1-2.
7
Update: NCCN breast cancer clinical practice guidelines.
J Natl Compr Canc Netw. 2004 Sep;2 Suppl 3:S-1-4.
8
Ipsilateral axillary tubercular lymphadenopathy, contralateral osseous tuberculosis in a case of ductal carcinoma of breast.
Indian J Cancer. 2008 Oct-Dec;45(4):182-4. doi: 10.4103/0019-509x.44671.
9
Fine-needle aspiration biopsy cytology of cutaneous calcinosis in a 74-year-old woman with dermatomyositis on methotrexate therapy: a case report.
Acta Cytol. 2008 Jul-Aug;52(4):454-8. doi: 10.1159/000325552.
10
Flagellate erythema as sign of paraneoplastic dermatomyositis.
Rheumatology (Oxford). 2021 Apr 6;60(4):2009. doi: 10.1093/rheumatology/keaa676.
引用本文的文献
1
Spatial Transcriptomics Identifies Immune-Stromal Niches Associated with Cancer in Adult Dermatomyositis.
bioRxiv. 2025 Mar 19:2025.03.19.644147. doi: 10.1101/2025.03.19.644147.
2
Dermatomyositis as a Paraneoplastic Syndrome in Cases of Aggressive Cervical Cancer.
Cureus. 2025 Feb 28;17(2):e79838. doi: 10.7759/cureus.79838. eCollection 2025 Feb.
3
Characteristics of Patients With Adult-Onset Dermatomyositis at 2 Tertiary Care Centres in Ontario, Canada.
J Cutan Med Surg. 2025 Mar-Apr;29(2):124-130. doi: 10.1177/12034754241301409. Epub 2024 Nov 26.
4
Cutaneous Manifestations in Patients with Dermatomyositis, Are They Only Skin Deep?
Dermatol Ther (Heidelb). 2024 Oct;14(10):2771-2785. doi: 10.1007/s13555-024-01266-1. Epub 2024 Sep 12.
5
Development of the Cutaneous Dermatomyositis Investigator Global Assessment (CDM-IGA): A De Novo IGA of Cutaneous Manifestations of Dermatomyositis.
Dermatol Ther (Heidelb). 2024 Aug;14(8):2127-2138. doi: 10.1007/s13555-024-01220-1. Epub 2024 Jul 8.
6
A Rare Case of Anti-TIF-1γ Antibody Positive Dermatomyositis in Adulthood.
J Investig Med High Impact Case Rep. 2024 Jan-Dec;12:23247096241263065. doi: 10.1177/23247096241263065.
7
Anti-nuclear matrix protein 2 antibody-positive amyopathic dermatomyositis presenting in a patient with prostate cancer: A case report.
Clin Case Rep. 2024 May 8;12(5):e8884. doi: 10.1002/ccr3.8884. eCollection 2024 May.
8
Remarkable remission of symptomatic dermatomyositis after curative breast cancer surgery.
Int Cancer Conf J. 2024 Jan 25;13(2):111-118. doi: 10.1007/s13691-023-00646-2. eCollection 2024 Apr.
9
Pitfalls in the Diagnosis and Management of an Unusual Presentation of Clinically Amyopathic Dermatomyositis: A Case Report Written With the Assistance of ChatGPT.
Cureus. 2023 Jul 14;15(7):e41879. doi: 10.7759/cureus.41879. eCollection 2023 Jul.
10
Immune checkpoint inhibitor therapy in a patient with small cell lung cancer and anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis: A case report.
Thorac Cancer. 2022 Oct;13(19):2808-2811. doi: 10.1111/1759-7714.14609. Epub 2022 Aug 18.
本文引用的文献
1
Breast cancer and dermatomyositis: a case study and literature review.
Curr Oncol. 2017 Oct;24(5):e429-e433. doi: 10.3747/co.24.3696. Epub 2017 Oct 25.
2
Cancer risk in dermatomyositis: a meta-analysis of cohort studies.
Am J Clin Dermatol. 2015 Apr;16(2):89-98. doi: 10.1007/s40257-015-0120-1.
3
Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis.
PLoS One. 2014 Apr 8;9(4):e94128. doi: 10.1371/journal.pone.0094128. eCollection 2014.
4
The evolving spectrum of polymyositis and dermatomyositis--moving towards clinicoserological syndromes: a critical review.
Clin Rev Allergy Immunol. 2014 Dec;47(3):264-73. doi: 10.1007/s12016-013-8387-6.
5
Meta-analysis of the association of dermatomyositis and polymyositis with cancer.
Br J Dermatol. 2013 Oct;169(4):838-47. doi: 10.1111/bjd.12564.
6
Magnetic resonance imaging of the idiopathic inflammatory myopathies: structural and clinical aspects.
Ann N Y Acad Sci. 2009 Feb;1154:101-14. doi: 10.1111/j.1749-6632.2009.04386.x.
7
Dermatomyositis: a clinicopathological study of 40 patients.
Am J Dermatopathol. 2009 Feb;31(1):61-7. doi: 10.1097/DAD.0b013e31818520e1.
8
Tubuloreticular structures in different types of myositis: implications for pathogenesis.
Ultrastruct Pathol. 2008 Jul-Aug;32(4):123-6. doi: 10.1080/01913120802209379.
9
Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study.
Ann Intern Med. 2001 Jun 19;134(12):1087-95. doi: 10.7326/0003-4819-134-12-200106190-00008.
10
Polymyositis and dermatomyositis (first of two parts).
N Engl J Med. 1975 Feb 13;292(7):344-7. doi: 10.1056/NEJM197502132920706.
Zotero 插件